Home
overview

Superbugs & Superdrugs USA 2016

2 Day Conference: NOV 14TH & 15TH
2 Interactive Workshops: NOV 16TH (For details visit the ASSOCIATED EVENTS tab)

Broadening horizons on the growing global threat of Antimicrobial resistance (AMR) for almost two decades at the sell-out Superbugs & Superdrugs conference in Europe, SMi is thrilled to announce the expansion of its antimicrobial portfolio of events across the Atlantic with the release of Superbugs & Superdrugs USA. This year’s show in Iselin, New Jersey, will play host to an audience of scientific leaders, funding bodies and drug discovery specialists, providing a focal point to discuss the latest clinical advancements and funding opportunities.

With huge interest from leaders in the field including PAHO/WHO, BARDA, NIH, Pfizer, AstraZeneca, Janssen and other senior industry representatives, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Superbugs & Superdrugs event to date.

The program will hone in on key topics such as public private partnerships, collaboration, R&D, scientific priorities for antibiotic discovery, novel antibacterial therapeutic approaches, antibiotic stewardship, rapid diagnostic tools, combination therapies, resistance prevention, plus much more!
 

 

LEARN about progress in the development of National Action Plans with exclusive keynotes from PAHO/WHO, NIAID and BARDA
CURRENT STATUS: Receive progressive insight into innovative developments in big pharma with updates on drug discovery
FAST TO MARKET: Evaluate zoonotic link between animals and humans to target emerging infectious diseases
DRUG DISCOVERY: Enable antibiotic drug development through novel approaches in treating gram-negative infections
TARGETING MECHANISIMS: Restore antibiotic sensitivity in multi-drug resistance infections
PREPARE: Prepare for outbreaks with case study insight into new paradigms for prevention and industry collaboration
 

 

 

CEOs, Chiefs, VPs, Directors, Heads, Principals of:

  • Antibacterial
  • Infectious Disease
  • R&D
  • Microbiology

or working in the area of superbugs and superdrugs from pharmaceutical, biotech and research organizations! 

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

William Weiss

William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

9:10 Global action plan on antimicrobial resistance

Pilar Ramon-Pardo

Pilar Ramon-Pardo, Advisor on Clinical Management of Infectious Diseases and Antimicrobial Resistance, PAHO/WHO

  • Strategic lines of action
  • Progress in the development of National Action Plans
  • Barriers and challenges for implementation of the Global Action Plan
  • The way forward
  • 9:50 NIAID and National Strategy for CARB

    Rosemarie Aurigemma

    Rosemarie Aurigemma, Chief, Biodefense Drug Development Section, DMID, NIAID, NIH

  • NIAID-supported research on antimicrobial drug resistance has helped facilitate translation of basic research discoveries from “bench to bedside”. 
  • The National Strategy for Combating Antibiotic Resistant Bacteria has allowed all facets of this drug discovery/development support to be boosted in order to drive greater interest and encourage investment and innovation.
  • NIAID hopes that the investment made will result in an upwelling of novel products into the pipeline and lead to new licensed products to stem the surge of resistant infections.
  • This presentation will describe NIAID programs that support antimicrobial product development, the results of the first year of the CARB initiative and the opportunities that lay ahead.
     
  • 10:30 Morning Coffee

    11:00 BARDA’s end-to-end support of antibacterial product development

    Christopher Houchens

    Christopher Houchens, Branch Chief, Antibacterials Program, BARDA

  • Launching the Biopharmaceutical Accelerator to repopulate the antimicrobial pipeline
  • Utilizing innovative public-private partnering mechanisms to stimulate clinical product development
  • Expanding the BARDA portfolio to include nontraditional antimicrobials
  • BARDA’s efforts to address objectives in the US National Action Plan for CARB
  • 11:40 Enabling drug discovery and development to address the crisis of antimicrobial resistance

    John Rex

    John Rex, Senior Vice President and Chief Strategy Officer, Infection Business Unit, AstraZeneca

  • New tools
  • New pathways
  • Remaining challenges
  • 12:20 Networking Lunch

    13:30 POL7080 – Polyphor’s new class of macrocycle antibiotic

    Daniel Obrecht

    Daniel Obrecht, Chief Scientific Officer, Polyphor

  • OL7080, Murapavadin, is the frontrunner of a new class of novel macrocycle antibiotic discovered and developed by Polyphor
  • It is a Pseudomonas-specific antibiotic, highly active on a broad panel of clinical isolates, including multi-drug resistant (MDR) strains and colistin-resistant isolates.
  • Phase I clinical trial in healthy volunteers in Europe demonstrated the clinical safety and tolerability of POL7080 and a Phase II study is on-going in ventilator-associated pneumonia (VAP)
  • Polyphor is developing a novel class of broad-spectrum Gran-negative antibiotics derived from our macrocycle technology platform
  • 14:10 Antimicrobial combination therapy: Use and disuse

    William Weiss

    William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

  • Rationale for the use of antibiotic combinations
  • Advantages / disadvantages of combining antimicrobial agents
  • Currently used antibiotic combinations
  • Novel and non-traditional antimicrobial combinations
  • 14:50 Innovative approaches to treating gram-negative infections

    Scott Coleman

    Scott Coleman, Head of Nonclinical Development, Spero Therapeutics

  • Turning gram-positive antibiotics into gram-negative therapeutics
  • The concept of potentiation
  • Proof of concept with generic Gram-positive agents 
  • 15:30 Afternoon Tea

    16:00 Microbial metagenomics-based antibiotic discovery

    David Pompliano

    David Pompliano, Co-Founder and CSO, Lodo Therapeutics

  • Accessing the biosynthetic output of overlooked unculturable microbes for new medicines
  • Surveying natural variants of known secondary metabolites for improved biological and pharmaceutical properties
  • Synthetic biological manipulation of biosynthetic gene clusters as a method of lead optimization
  • 16:40 Targeting mechanisms of resistance using protein resistance neutralizers

    David Cook

    David Cook, Chief Scientific Officer , Blueberry Therapeutics Ltd.

  • Restoring antibiotic sensitivity in multi-drug resistance infections
  • Direct targeting of resistance gene products using protein “resistance neutralizers”
  • Enhance antibiotic effects, expand efficacy and maintain clinical usefulness
  • 17:20 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    William Weiss

    William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

    9:10 First to know and fast to market

    Mahesh Kumar

    Mahesh Kumar, Vice President, Global Biological Research and Development, Zoetis

  • Infectious diseases between animals and people
  • First to know and fast to market
  • Making a difference
  • 9:50 Novel protein-based biologics for the treatment and prevention of serious bacterial infections

    Anthony Simon Lynch

    Anthony Simon Lynch, Senior Scientific Director, Janssen Fellow & Incubator Leader, Janssen Research & Development, LLC

  • Bacteriophage-derived lysins, antibody-drug conjugates and novel protein scaffolds
  • Challenges in discovery and development
  • Potential for clinical utility as stand-alone agents or as adjuncts to existing therapies
  • 10:30 Morning Coffee

    11:00 Progress towards developing vaccines for the prevention of Staphylococcus aureus infections

    Annaliesa Anderson

    Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer

  • Staphylococcus aureus causes serious infections in healthcare settings
  • Antibiotic resistance make infections harder to treat and non-antibiotic prophylactic approaches could address this unmet medical need 
  • Approaches to design and develop vaccines for the prevention of S. aureus infections will be discussed
  • 11:40 The novel strategy to fight multidrug resistance by multiple drugs synergism, based on docking in drug design and TRIZ

    Boris Farber

    Boris Farber, CEO, Noigel, LLC

  • The novel strategy to fight multidrug resistance
  • Multiple drugs synergism in view of multidrug resistance
  • The novel strategy to decrease antibiotics toxicity
  • 12:20 Networking Lunch

    13:30 What can be done in order to be successful?

    Domingo  Gargallo-Viola

    Domingo Gargallo-Viola, Co-Founder and CSO, ABAC Therapeutics

  • Novel approaches and compounds
  • New scenarios in innovation
  • Rational health system
  • 14:10 Addressing the evolving challenge of ß-lactamase mediated antimicrobial resistance: ETX2514, a next-generation BLI with potent broad spectrum activity against Class A, C and D enzymes

    Alita Miller

    Alita Miller, Head of Bioscience, Entasis Therapeutics

  • ETX2514 is a novel diazabicyclooctenone with potent, broad spectrum inhibitory activity against Class A, C and D serine β-lactamases
  • ETX2514 restores the antimicrobial activity of a variety of β-lactams against multi-drug resistant Gram-negative pathogens
  • The combination of ETX2514 and sulbactam is highly effective in vitro and in vivo against clinical MDR and XDR A. baumannii
  • 14:50 Afternoon Tea

    15:20 Collaborative development of novel drugs to prevent infection

    Ian Hayter

    Ian Hayter, Projects Director, Destiny Pharma Ltd

  • Development of clinical stage assets through  collaborative ventures
  • Progression of XF-73, an alternative to traditional antibiotics
  • Preventing infection and addressing resistance
  • 16:00 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Annaliesa Anderson

    Annaliesa Anderson

    Vice President and CSO Bacterial Vaccines, Pfizer
    Anthony Simon Lynch

    Anthony Simon Lynch

    Senior Scientific Director, Janssen Fellow & Incubator Leader, Janssen Research & Development, LLC
    Christopher Houchens

    Christopher Houchens

    Branch Chief, Antibacterials Program, BARDA
    John Rex

    John Rex

    Senior Vice President and Chief Strategy Officer, Infection Business Unit, AstraZeneca
    Mahesh Kumar

    Mahesh Kumar

    Vice President, Global Biological Research and Development, Zoetis
    Pilar Ramon-Pardo

    Pilar Ramon-Pardo

    Advisor on Clinical Management of Infectious Diseases and Antimicrobial Resistance, PAHO/WHO
    Rosemarie Aurigemma

    Rosemarie Aurigemma

    Chief, Biodefense Drug Development Section, DMID, NIAID, NIH

    Alita Miller

    Head of Bioscience, Entasis Therapeutics
    Alita Miller

    Annaliesa Anderson

    Vice President and CSO Bacterial Vaccines, Pfizer
    Annaliesa Anderson

    Anthony Simon Lynch

    Senior Scientific Director, Janssen Fellow & Incubator Leader, Janssen Research & Development, LLC
    Anthony Simon Lynch

    Boris Farber

    CEO, Noigel, LLC
    Boris Farber

    Christopher Houchens

    Branch Chief, Antibacterials Program, BARDA
    Christopher Houchens

    Daniel Obrecht

    Chief Scientific Officer, Polyphor
    Daniel Obrecht

    David Cook

    Chief Scientific Officer , Blueberry Therapeutics Ltd.
    David Cook

    David Pompliano

    Co-Founder and CSO, Lodo Therapeutics
    David Pompliano

    Domingo Gargallo-Viola

    Co-Founder and CSO, ABAC Therapeutics
    Domingo  Gargallo-Viola

    Ian Hayter

    Projects Director, Destiny Pharma Ltd
    Ian Hayter

    John Rex

    Senior Vice President and Chief Strategy Officer, Infection Business Unit, AstraZeneca
    John Rex

    Mahesh Kumar

    Vice President, Global Biological Research and Development, Zoetis
    Mahesh Kumar

    Pilar Ramon-Pardo

    Advisor on Clinical Management of Infectious Diseases and Antimicrobial Resistance, PAHO/WHO
    Pilar Ramon-Pardo

    Rosemarie Aurigemma

    Chief, Biodefense Drug Development Section, DMID, NIAID, NIH
    Rosemarie Aurigemma

    Scott Coleman

    Head of Nonclinical Development, Spero Therapeutics
    Scott Coleman

    William Weiss

    Director of Pre-Clinical Services, University of North Texas Health Science Center
    William Weiss

    Sponsors and Exhibitors

    Official Media Partner

    Official Publication

    Supporters

    Workshops

    The Use of Animal Models in Pre-Clinical Drug Development
    Workshop

    The Use of Animal Models in Pre-Clinical Drug Development

    Renaissance Woodbridge Hotel
    16th November 2016
    Iselin, USA

    Opportunities and challenges in development of new antibacterial therapeutics
    Workshop

    Opportunities and challenges in development of new antibacterial therapeutics

    Renaissance Woodbridge Hotel
    16th November 2016
    Iselin, USA

    VENUE

    Renaissance Woodbridge Hotel

    515 US Highway 1 South, Iselin, New Jersey, USA

    Your simple delights will become memorable moments at Renaissance Woodbridge Hotel. This distinctive hotel in Edison, New Jersey, features 269 modern guest rooms, including 42 suites, and more than 25,000 square feet of flexible meeting space. Our hotel's location is centrally located amidst corporate offices and tourist attraction. Our accommodations stand out from other hotels in Edison, NJ, and provide a sophisticated retreat for families and business travelers alike. Marriott's Plug-in panels and 37-inch LCD HD TVs allow guests simultaneous connectivity to laptops, iPods and DVD players. We are one of the most conveniently situated hotels at the crossroads of U.S. Routes 1 and 9. We are also just five minutes from Woodbridge Center Mall, 15 minutes south of Newark Liberty International Airport (EWR) and less than one mile from the Metropark train station. With our premier location and amenities, our Edison accommodations provide an advantageous travel destination.

    HOTEL BOOKING FORM

    An Interview with The Medicines Company

    Download

    An Interview with Boris Farber, CEO, Noigel LLC

    Download

    Superbugs & Superdrugs USA Preliminary List of Attendees

    Download

    An Interview with Pfizer

    Download

    An Interview with Blueberry Therapeutics

    Download

    An Interview with Janssen

    Download

    An Interview With BARDA

    Download

    Past Attendees List

    Download

    Sponsors and Exhibitors


    Noigel LLC

    Sponsors and Exhibitors
    http://www.noigel.eu/

    Noigel LLC was established in 2010 by a group of scientists as the biopharmaceutical startup company to study and develop drugs based on principle multiple synergisms, based on TRIZ and modern Design and Technologies in different fields: anticancer, antiviral, antimicrobial drugs with new properties.


    Polyphor

    Sponsors and Exhibitors
    http://polyphor.com/

    Polyphor is a Swiss Pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs. Macrocycles represent a new drug class complementary to the traditional small molecules and large biopharmaceuticals. Polyphor leverages its unique and proprietary technology platforms to develop its own product portfolio and to pursue licensing and collaboration opportunities with industry partners. The company’s lead drug candidates include POL6326, Balixafortide, (Phase Ib), a CXCR4 antagonist, for stem cell transplantation, tissue repair and combination treatments in oncology; POL7080, Murepavadin, (Phase II), a highly specific antibiotic with a novel mode-of-action to treat Pseudomonas infections; and POL6014 (Phase Ib), an inhaled inhibitor of neutrophil elastase for the treatment of CF and other lung diseases. Polyphor is a privately held company with about 100 employees, headquartered in Allschwil, near Basel.

    Media Partners


    American Pharmaceutical Review

    Official Media Partner
    http://www.americanpharmaceuticalreview.com

    American Pharmaceutical Review is the leading review of business and technology for the pharmaceutical industry throughout North America. Each issue offers unbiased editorial on drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing and regulatory affairs. American Pharmaceutical keeps its 30,000 readers including senior executives, technical personnel, scientists, and others fully abreast of the latest trends and developments in the process of pharmaceutical manufacturing.


    Rapid Microbiology.com

    Official Media Partner
    http://www.rapidmicrobiology.com

    rapidmicrobiology.com - keep up-to-date with all the latest products for your pharmaceutical microbiology laboratory, subscribe to the rapidmicrobiology.com newsletter http://www.rapidmicrobiology.com/Newsletter.php


    Colorado Bioscience

    Official Media Partner
    http://www.cobioscience.com/

    The Colorado Bioscience Association is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry.


    Global Biodefense

    Official Media Partner
    http://www.globalbiodefense.com/

    Global Biodefense publishes the latest news on vaccine and therapeutics countermeasure development, biosurveillance and detection technologies, food safety and biosecurity, and CBRN incident preparedness and response. Visit our website to access daily news updates, organization profiles, conference listings, and the latest in funding opportunities for advancing biodefense technology.

    Media Partners


    Int. J. of Bioinformatics Research and Applications

    Official Publication
    http://www.inderscience.com/ijbra

    Bioinformatics is an interdisciplinary research field that combines biology, computer science, mathematics and statistics into a broad-based field that will have profound impacts on all fields of biology. The emphasis of IJBRA is on basic bioinformatics research methods, tool development, performance evaluation and their applications in biology. IJBRA addresses the most innovative developments, research issues and solutions in bioinformatics and computational biology and their applications.


    Int. J. of Biotechnology

    Official Publication
    http://www.inderscience.com/ijbt

    IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.


    International Journal of Risk Assessment and Management

    Official Publication
    http://www.inderscience.com/ijram

    IJRAM is an interdisciplinary and refereed journal that provides cross learning between: • Different business and economics, as well as scientific and technological, disciplines • Energy industries, environmental and ecological systems • Safety, public health and medical services • Software services, reliability and safety

    Media Partners


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Conference-Service.com

    Supporters
    http://www.conference-service.com/

    COMS is a web application for managing delegate registration, payment, paper submission and paper review. Written in Perl and C, with a MySQL database at the back end, it is a comprehensive and powerful, yet easy to use solution for online conference management.


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    SelectScience

    Supporters
    http://www.selectscience.net/register?utm_source=Media-Partner&utm_medium=Website&utm_campaign=SMI

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover the latest drug discovery and development technologies, products and techniques with product reviews, videos, application notes and news articles. Become a member for free today.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    PMR

    Supporters
    http://www.pmrcorporate.com

    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


    Pharmaceutical Outsourcing

    Supporters
    http://www.pharmoutsourcing.com

    Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry to our 15,000 readers in North America.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    KBI Biopharma

    Supporters
    http://www.kbibiopharma.com

    KBI also provides services from its industry-leading Particle Characterization Core Facility, including a full range of particle detection methods and data analysis utilizing MFI, Archimedes, NTA, Helix, Morphologi G3-ID, and Viscosizer instruments.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    BioPharm Insight

    Supporters
    http://www.infinata.com/biopharma-solution/by-product/biopharm-insight.html

    BioPharm Insight is your definitive guide to the global life sciences community. Subscribers take action on forward-looking intelligence uncovered by an independent team of investigative journalists, and make strategic business decisions using the most comprehensive and powerful real-time database of market analytics and key contacts. Featuring an intuitive online interface and exclusive Active IntelT relational content technology, BioPharm Insight provides an unrivaled capability to segment and analyze the industry with detailed and searchable profiles.


    Copybook - Pharmaceutical

    Supporters
    http://www.copybook.com/pharmaceutical

    Copybook is a global business network with many pharmaceutical events, exhibitions and seminars. We encourage business-to-business transactions and work tirelessly to gain our customers new business contracts worldwide. You can add events, companies and associations for free. When you are a member, you can add your company to the events listed in order to encourage other visitors to arrange meetings and appointments at those events to facilitate new business contracts. Want to see how we can increase your business network and transactions? SIGN UP FOR FREE today! Copybook – Your Global Business Network


    Labhoo

    Supporters
    http://www.labhoo.com



    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


    Packaging-gateway

    Supporters
    http://www.packaging-gateway.com

    Packaging executives from around the world use the website to keep abreast of the latest industry developments and make informed purchasing decisions along the entire supply chain. Packaging-gateway.com provides up-to-date industry intelligence through: •Regularly updated news bulletins and company press releases •Feature articles written by leading industry figures •Detailed research reports containing the latest market statistics •The latest packaging related projects •White papers containing the latest analysis, insights and technology solutions


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Technology Networks

    Supporters
    http://www.technologynetworks.com

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Drug Target Review

    Supporters
    http://www.drugtargetreview.com

    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Thomson Reuters

    Supporters
    http://thomsonreuters.com/products_services/science/

    Thomson Reuters is the leading source of intelligent information for professionals around the world. We provide essential information to keep you in touch with the rapidly-changing pharmaceutical and chemical markets, expert services to help you make informed, early decisions, and intuitive technology to manage and support your discovery and development activities. Our products give you the intelligence, tools and expertise to help you optimize your IP portfolio, monitor industry developments, identify licensing and partnering opportunities, deliver successful regulatory submissions, and support your scientific messaging, marketing, product positioning, and awareness campaigns.


    One Nucleus

    Supporters
    http://www.onenucleus.com

    Established in May 2010, One Nucleus is the result of the merger of ERBI and London Biotechnology Network. One Nucleus is a not-for-profit membership organisation for international life science and healthcare companies and the largest of its kind in Europe. The company is based in Cambridge UK and London, at the heart of Europe's largest cluster. The 470 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial Service Providers.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    American Laboratory

    Supporters
    http://www.americanlaboratory.com

    For laboratory managers and researchers utilizing analytical chemistry and its applications, seeking knowledge on new technologies, methods, applications, and products, the American Laboratory® publication platform provides comprehensive technology coverage for laboratory professionals at all stages of their careers. Unlike single-channel publications, American Laboratory® is a multidisciplinary resource that engages scientists through print, digital, mobile, multimedia, and social channels to provide practical information and solutions for cutting-edge results. American Laboratory® serves the need of global community of laboratory professionals for communicating relevant technical advances and insights. Globally, American Laboratory® reaches out to subscribers by offering digital distribution plus premium print in North America. Digital communications utilize internet, mobile and social channels.


    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 116 titles and 200 plus open access journals and print/online book series (Bentham eBooks). Bentham Science answers the information needs of the pharmaceutical and biomedical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.113) and Current Medicinal Chemistry (Impact Factor 4.859): FREE online journals and information: www.benthamscience.com


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Renaissance Woodbridge Hotel

    515 US Highway 1 South
    Iselin 08830
    USA

    Renaissance Woodbridge Hotel

    Your simple delights will become memorable moments at Renaissance Woodbridge Hotel. This distinctive hotel in Edison, New Jersey, features 269 modern guest rooms, including 42 suites, and more than 25,000 square feet of flexible meeting space. Our hotel's location is centrally located amidst corporate offices and tourist attraction. Our accommodations stand out from other hotels in Edison, NJ, and provide a sophisticated retreat for families and business travelers alike. Marriott's Plug-in panels and 37-inch LCD HD TVs allow guests simultaneous connectivity to laptops, iPods and DVD players. We are one of the most conveniently situated hotels at the crossroads of U.S. Routes 1 and 9. We are also just five minutes from Woodbridge Center Mall, 15 minutes south of Newark Liberty International Airport (EWR) and less than one mile from the Metropark train station. With our premier location and amenities, our Edison accommodations provide an advantageous travel destination.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.